Blood TRPC6 mRNA as a Biomarker for Diagnosing Alzheimer's Disease: A Nationwide, Multicentre Trial in China

Blood TRPC6 mRNA levels exhibited excellent diagnostic utility in identifying patients with AD from CU individuals. As a blood biomarker, TRPC6 mRNA levels offer a feasible, scalable, and cost-effective diagnostic tool that could serve as a standalone index for AD.

Authors

Qianhua Zhao
Mei Pu

Institutions

Fudan University (CN)
Huashan Hospital (CN)

Publication Details

Journal: Alzheimer s & Dementia
Published: 2025-12-01
DOI: https://doi.org/10.1002/alz70856_098827
Primary Topic: Dementia and Cognitive Impairment Research
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Blood TRPC6 mRNA as a Biomarker for Diagnosing Alzheimer's Disease: A Nationwide, Multicentre Trial in China

Qianhua Zhao, Mei Pu

Dec 1, 2025

Alzheimer s & Dementia

Dementia and Cognitive Impairment Research

article

Blood TRPC6 mRNA as a Biomarker for Diagnosing Alzheimer's Disease: A Nationwide, Multicentre Trial in China

Qianhua Zhao, Mei Pu

December 1, 2025article en

Abstract

Alzheimer s & DementiaVol. 21(S2)

Fudan University (CN), Huashan Hospital (CN)

Openalex Percentile: Top 35%

Dementia and Cognitive Impairment Research

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Blood TRPC6 mRNA as a Biomarker for Diagnosing Alzheimer's Disease: A Nationwide, Multicentre Trial in China — Qianhua Zhao, Mei Pu · Alzheimer s & Dementia (2025) | TGRS Research Map | TGRS